Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 89
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 111(4): 1521-6, 2014 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-24434559

RESUMO

The biochemical mechanisms that regulate the process of cancer metastasis are still poorly understood. Because kinases, and the signaling pathways they comprise, play key roles in regulation of many cellular processes, we used an unbiased RNAi in vitro screen and a focused cDNA in vivo screen against human kinases to identify those with previously undocumented roles in metastasis. We discovered that G-protein-coupled receptor kinase 3 (GRK3; or ß-adrenergic receptor kinase 2) was not only necessary for survival and proliferation of metastatic cells, but also sufficient to promote primary prostate tumor growth and metastasis upon exogenous expression in poorly metastatic cells in mouse xenograft models. Mechanistically, we found that GRK3 stimulated angiogenesis, at least in part through down-regulation of thrombospondin-1 and plasminogen activator inhibitor type 2. Furthermore, GRK3 was found to be overexpressed in human prostate cancers, especially in metastatic tumors. Taken together, these data suggest that GRK3 plays an important role in prostate cancer progression and metastasis.


Assuntos
Quinase 3 de Receptor Acoplado a Proteína G/fisiologia , Metástase Neoplásica , Neoplasias da Próstata/patologia , Proliferação de Células , Progressão da Doença , Humanos , Masculino , Inibidor 2 de Ativador de Plasminogênio/genética , Neoplasias da Próstata/metabolismo , Trombospondina 1/genética
2.
Biochemistry ; 52(18): 3102-18, 2013 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-23570341

RESUMO

Tyro3, a member of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases, has emerged as a potential oncogene in melanoma. Here, we confirm that Tyro3 is specifically overexpressed in primary melanoma samples and show that Tyro3 is expressed at varying levels in numerous melanoma cell lines. Short hairpin RNA-mediated knockdown of Tyro3 led to significant cell death via apoptotic mechanisms in nearly all melanoma cell lines tested, regardless of the BRAF or NRAS mutation status or co-expression of Axl and/or Mer. We generated soluble and monomeric versions of the human Tyro3 extracellular domain and human Gas6 for affinity measurements and correlated these values with the level of Gas6 required to induce Tyro3 signaling in cellular assays. Calcium was critical for the correct folding of Gas6 and its binding to Tyro3. In melanoma cell lines, Gas6 induced Tyro3 phosphorylation and downstream Akt phosphorylation without apparent effects on Erk. We generated monoclonal antibodies (mAbs) against Tyro3 to examine their effect on survival signaling in melanoma cell lines. The mAbs generated against Tyro3 included nonligand blockers, partial blockers, and competitive ligand blockers. A number of weak and partial ligand blockers (all recognizing the Tyro3 Ig domains) were the most effective at blocking ligand-mediated downstream signaling of Tyro3. Overall, these data indicate that Tyro3 may confer increased survival signals in melanoma cells and can be stymied using inhibitory mAbs. These mAbs may be useful for further investigations of the role of Tyro3 in melanoma.


Assuntos
Anticorpos Monoclonais/imunologia , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Melanoma/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Receptores Proteína Tirosina Quinases/metabolismo , Western Blotting , Varredura Diferencial de Calorimetria , Divisão Celular , Linhagem Celular Tumoral , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Dicroísmo Circular , Ensaio de Imunoadsorção Enzimática , Humanos , Imunoprecipitação , Melanoma/imunologia , Melanoma/patologia , Fosforilação , RNA Mensageiro/análise , Receptores Proteína Tirosina Quinases/imunologia
4.
Genes Dev ; 25(8): 814-30, 2011 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-21498571

RESUMO

pRB-mediated inhibition of cell proliferation is a complex process that depends on the action of many proteins. However, little is known about the specific pathways that cooperate with the Retinoblastoma protein (pRB) and the variables that influence pRB's ability to arrest tumor cells. Here we describe two shRNA screens that identify kinases that are important for pRB to suppress cell proliferation and pRB-mediated induction of senescence markers. The results reveal an unexpected effect of LATS2, a component of the Hippo pathway, on pRB-induced phenotypes. Partial knockdown of LATS2 strongly suppresses some pRB-induced senescence markers. Further analysis shows that LATS2 cooperates with pRB to promote the silencing of E2F target genes, and that reduced levels of LATS2 lead to defects in the assembly of DREAM (DP, RB [retinoblastoma], E2F, and MuvB) repressor complexes at E2F-regulated promoters. Kinase assays show that LATS2 can phosphorylate DYRK1A, and that it enhances the ability of DYRK1A to phosphorylate the DREAM subunit LIN52. Intriguingly, the LATS2 locus is physically linked with RB1 on 13q, and this region frequently displays loss of heterozygosity in human cancers. Our results reveal a functional connection between the pRB and Hippo tumor suppressor pathways, and suggest that low levels of LATS2 may undermine the ability of pRB to induce a permanent cell cycle arrest in tumor cells.


Assuntos
Proteínas Serina-Treonina Quinases/metabolismo , RNA Interferente Pequeno/fisiologia , Proteína do Retinoblastoma/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Ciclo Celular/genética , Ciclo Celular/fisiologia , Linhagem Celular , Linhagem Celular Tumoral , Proliferação de Células , Imunoprecipitação da Cromatina , Citometria de Fluxo , Humanos , Immunoblotting , Perda de Heterozigosidade/genética , Análise de Sequência com Séries de Oligonucleotídeos , Fosforilação , Reação em Cadeia da Polimerase , Ligação Proteica/genética , Ligação Proteica/fisiologia , Proteínas Serina-Treonina Quinases/genética , Proteínas Tirosina Quinases/metabolismo , RNA Interferente Pequeno/genética , Proteína do Retinoblastoma/genética , Transdução de Sinais/genética , Transdução de Sinais/fisiologia , Proteínas Supressoras de Tumor/genética , Quinases Dyrk
5.
Proc Natl Acad Sci U S A ; 108(5): 2058-63, 2011 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-21233418

RESUMO

Resistance to tamoxifen in breast cancer patients is a serious therapeutic problem and major efforts are underway to understand underlying mechanisms. Resistance can be either intrinsic or acquired. We derived a series of subcloned MCF7 cell lines that were either highly sensitive or naturally resistant to tamoxifen and studied the factors that lead to drug resistance. Gene-expression studies revealed a signature of 67 genes that differentially respond to tamoxifen in sensitive vs. resistant subclones, which also predicts disease-free survival in tamoxifen-treated patients. High-throughput cell-based screens, in which >500 human kinases were independently ectopically expressed, identified 31 kinases that conferred drug resistance on sensitive cells. One of these, HSPB8, was also in the expression signature and, by itself, predicted poor clinical outcome in one cohort of patients. Further studies revealed that HSPB8 protected MCF7 cells from tamoxifen and blocked autophagy. Moreover, silencing HSBP8 induced autophagy and caused cell death. Tamoxifen itself induced autophagy in sensitive cells but not in resistant ones, and tamoxifen-resistant cells were sensitive to the induction of autophagy by other drugs. These results may point to an important role for autophagy in the sensitivity to tamoxifen.


Assuntos
Antineoplásicos Hormonais/farmacologia , Autofagia/efeitos dos fármacos , Proteínas Quinases/metabolismo , Tamoxifeno/farmacologia , Linhagem Celular Tumoral , Estudos de Coortes , Resistencia a Medicamentos Antineoplásicos , Inativação Gênica , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/fisiologia , Humanos , Chaperonas Moleculares , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/fisiologia
6.
Proc Natl Acad Sci U S A ; 107(35): 15455-60, 2010 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-20713694

RESUMO

Chromosomal instability and the subsequent genetic mutations are considered to be critical factors in the development of the majority of solid tumors, but the mechanisms by which a stable diploid cell loses the ability to maintain genomic integrity are not well characterized. We have approached this critical issue through the use of high-throughput screens in untransformed diploid epithelial cells. In a screen of a cDNA library, we identified 13 kinases whose overexpression leads to increased ploidy. In a series of shRNA screens, we identified 16 kinases whose loss leads to increased ploidy. In both cDNA and shRNA screens, the majority of hits have not been linked previously to genomic stability. We further show that sustained loss of the shRNA screening hits leads to multipolar spindles and heterogeneous chromosome content, two characteristics of chromosomal instability. Loss of several of the kinases leads to loss of contact inhibition and to anchorage-independent growth, vital traits acquired during tumor development. We anticipate that this work will serve as a template for the comprehensive identification of pathways whose dysregulation can drive tumorigenesis through impaired karyotypic maintenance.


Assuntos
Instabilidade Cromossômica/genética , Diploide , Células Epiteliais/metabolismo , Proteínas Quinases/genética , Aneuploidia , Linhagem Celular , Células Epiteliais/citologia , Perfilação da Expressão Gênica/métodos , Biblioteca Gênica , Humanos , Hibridização in Situ Fluorescente , Mitose/genética , Modelos Genéticos , Interferência de RNA
7.
Proc Natl Acad Sci U S A ; 107(35): 15461-6, 2010 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-20713695

RESUMO

Chromosomal instability and the subsequent genetic mutations are considered to be critical factors in the development of the majority of solid tumors. Here, we describe how the nucleoside diphosphate kinase Nm23-H1, a protein with a known link to cancer progression, regulates a critical step during cytokinesis. Nm23-H1 acts to provide a local source of GTP for the GTPase dynamin. Loss of Nm23-H1 in diploid cells leads to cytokinetic furrow regression, followed by cytokinesis failure and generation of tetraploid cells. Loss of dynamin phenocopies loss of Nm23-H1, and ectopic overexpression of WT dynamin complements the loss of Nm23-H1. In the absence of p53 signaling, the tetraploid cells resulting from loss of Nm23-H1 continue cycling and develop classic hallmarks of tumor cells. We thus provide evidence that the loss of Nm23-H1, an event suspected to promote metastasis, may additionally function at an earlier stage of tumor development to drive the acquisition of chromosomal instability.


Assuntos
Instabilidade Cromossômica/genética , Citocinese/genética , Dinaminas/genética , Nucleosídeo NM23 Difosfato Quinases/genética , Western Blotting , Ciclo Celular/genética , Linhagem Celular , Células Cultivadas , Senescência Celular/genética , Dinaminas/metabolismo , Citometria de Fluxo , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Células HeLa , Humanos , Microscopia de Fluorescência , Mitose/genética , Nucleosídeo NM23 Difosfato Quinases/metabolismo , Poliploidia , Interferência de RNA , Reação em Cadeia da Polimerase Via Transcriptase Reversa
8.
Proc Natl Acad Sci U S A ; 107(28): 12463-8, 2010 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-20616055

RESUMO

Cervical carcinomas are initiated through a series of well-defined stages that rely on the expression of human papillomavirus (HPV) oncogenes. A panel of 100 small hairpin RNAs that target essential kinases in many tumor types was used to study the stepwise appearance of kinase requirements during cervical tumor development. Twenty-six kinases were commonly required in three cell lines derived from frank carcinomas, and each kinase requirement was traced to the specific stage in which the requirement emerged. Six kinases became required following HPV-induced immortalization, and the requirement for two kinases, SGK2 and PAK3, was mapped to the inactivation of p53 in primary human epithelial cells. Loss of the p53 tumor suppressor in other primary epithelial cells also induced dependence on SGK2 and PAK3. Hence, SGK2 and PAK3 provide important cellular functions following p53 inactivation, fulfilling the classical definition of synthetic lethality; loss of p53, SGK2, or PAK3 alone has little effect on cell viability, whereas loss of p53 together with either SGK2 or PAK3 loss leads to cell death. Whereas tumor suppressor gene mutations are not directly druggable, other proteins or pathways that become obligatory to cell viability following tumor suppressor loss provide theoretical targets for tumor suppressor-specific drug discovery efforts. The kinases SGK2 and PAK3 may thus represent such targets for p53-specific drug development.


Assuntos
Genes Supressores de Tumor , Genes p53 , Proteínas/metabolismo , Proteína Supressora de Tumor p53/biossíntese , Proteína Supressora de Tumor p53/metabolismo , Carcinoma/genética , Carcinoma/virologia , Feminino , Humanos , Masculino , Papillomaviridae/genética , Papillomaviridae/metabolismo , Fosfotransferases/genética , Fosfotransferases/metabolismo , Proteínas Quinases/genética , Proteínas Quinases/metabolismo , Proteínas/genética , Proteína Supressora de Tumor p53/genética , Neoplasias do Colo do Útero/genética , Neoplasias do Colo do Útero/metabolismo , Neoplasias do Colo do Útero/virologia , Quinases Ativadas por p21
9.
Proc Natl Acad Sci U S A ; 105(43): 16472-7, 2008 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-18948591

RESUMO

shRNA loss-of-function screens were used to identify kinases that were rate-limiting for promoting cell proliferation and survival. Here, we study the differences in kinase requirements among various human cells, including freshly prepared primary cells, isogenic cells, immortalized cells, and cancer cell lines. Closely related patterns of kinase requirements among the various cell types were observed in three cases: (i) in repeat experiments using the same cells, (ii) with multiple populations of freshly prepared primary epithelial cells isolated from the same tissue source, and (iii) between nearly isogenic cells that differ from each other by the expression of a single gene. Other commonly used cancer cell lines were distinct from one another, even when they were isolated from similar tumor types. Even primary cells of different lineages isolated from the same tissue source showed many differences. The differences in kinase requirements among cell lines observed in this study suggest that the control of proliferation and survival may be significantly different between cell lines and that simple comparisons from any one cell to another may be misleading. Although the regulation of cell proliferation and survival are heavily studied areas, we did not see a bias in these screens toward the identification of previously known and well studied kinases, suggesting that our knowledge of molecular events in these areas is still meager.


Assuntos
Células/enzimologia , Fosfotransferases/fisiologia , Linhagem Celular Tumoral , Proliferação de Células , Sobrevivência Celular , Células/citologia , Células Cultivadas , Inativação Gênica , Humanos , Fosfotransferases/análise , Fosfotransferases/genética , RNA Interferente Pequeno
10.
Proc Natl Acad Sci U S A ; 105(43): 16484-9, 2008 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-18948595

RESUMO

Clear cell renal carcinomas are the most common form of kidney cancer and frequently are linked to biallelic inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene. The VHL gene product, pVHL, has multiple functions including directing the polyubiquitylation of the HIF transcription factor. We screened 100 shRNA vectors, directed against 88 kinases, for their ability to inhibit the viability of VHL-/- renal carcinoma cells preferentially compared with isogenic cells in which pVHL function was restored. shRNAs for "hits" identified in the primary screen were interrogated in secondary screens that included shRNA titration studies. Multiple shRNAs against CDK6, MET, and MAP2K1 (also known as MEK1) preferentially inhibited the viability of 786-O and RCC4 VHL-/- cells compared with their wild-type pVHL-reconstituted counterparts. The sensitivity of pVHL-proficient cells to these shRNAs was not restored upon HIF activation, suggesting that loss of an hypoxia-inducible factor (HIF)-independent pVHL function formed the basis for selectivity. A small-molecule Cdk4/6 inhibitor displayed enhanced activity against VHL-/- renal carcinoma cells, suggesting that in some cases hits from shRNA screens such as described here might translate into therapeutic targets.


Assuntos
Carcinoma de Células Renais/enzimologia , Fosfotransferases/análise , Proteína Supressora de Tumor Von Hippel-Lindau/genética , Carcinoma de Células Renais/patologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Quinase 6 Dependente de Ciclina/antagonistas & inibidores , Quinase 6 Dependente de Ciclina/genética , Humanos , MAP Quinase Quinase 1/genética , Fosfotransferases/genética , Fosfotransferases/fisiologia , Inibidores de Proteínas Quinases/farmacologia , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-met , RNA Interferente Pequeno/farmacologia , Receptores de Fatores de Crescimento/genética
11.
Proc Natl Acad Sci U S A ; 105(43): 16490-5, 2008 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-18948597

RESUMO

Functional differences among human cells have been difficult to identify by standard biochemical methods. Loss-of-function shRNA screens provide an unbiased method to compare protein requirements across cell lines. In previous work, we have studied kinase requirements in two settings, either among a panel of cells from numerous tissues or between two cell lines that differ only by the expression of a chosen oncoprotein or tumor suppressor protein. Here we examine the patterns of kinase requirements between two unrelated cells, the cervical carcinoma cell line HeLa and the renal carcinoma cell line 786-O. By using time courses of cell proliferation after shRNA transduction and by introducing different levels of the shRNAs, we were able to carefully compare the kinase requirements. These comparisons identified 10 kinases that were required in HeLa but not 786-O, and 5 kinases that were required in 786-O but not HeLa. The patterns of growth inhibition due to particular sets of shRNAs in a tumor cell line were shown to be similar in some but not all cell lines derived from the same tissue-specific cancer type. Differential kinase requirements promise to be useful in distinguishing important cell-to-cell functional variations and may lead to the identification of fingerprints for different physiological cell states.


Assuntos
Neoplasias Renais/enzimologia , Fosfotransferases/fisiologia , Neoplasias do Colo do Útero/enzimologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Feminino , Humanos , Neoplasias Renais/patologia , Cinética , Fosfotransferases/análise , Fosfotransferases/genética , Interferência de RNA , RNA Interferente Pequeno/farmacologia , Titulometria , Neoplasias do Colo do Útero/patologia
12.
Proc Natl Acad Sci U S A ; 105(43): 16478-83, 2008 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-18948598

RESUMO

Human papillomavirus (HPV) oncoproteins subvert cellular signaling pathways, including kinase pathways, during the carcinogenic process. To identify kinases targeted by the HPV16 E7 oncoprotein, shRNA kinase screens were performed in RKO colorectal carcinoma cell lines that differ only in their expression of HPV16 E7. Our screens identified kinases that were essential for the survival of RKO cells, but not essential for RKO cells expressing HPV16 E7. These kinases include CDK6, ERBB3, FYN, AAK1, and TSSK2. We show that, as predicted, CDK6 knockdown inhibits pRb phosphorylation and induces S-phase depletion, thereby inhibiting cell viability. Knockdown of ERBB3, FYN, AAK1, and TSSK2 induces a similar loss of cell viability through an unknown mechanism. Expression of the HPV16 E7 oncoprotein, known to bind and degrade pRb, relieves the requirement of these kinases. These studies demonstate that expression of a single oncoprotein can dramatically alter kinase sensitivity in human cells. The shRNA screens used here perform analogously to genetic interaction screens commonly used in genetically tractable organisms such as yeast, and thus represent an exciting method for unbiased identification of cellular signaling pathways targeted by cancer mutations.


Assuntos
Proteínas Oncogênicas Virais/farmacologia , Fosfotransferases/fisiologia , Ciclo Celular , Linhagem Celular Tumoral , Sobrevivência Celular , Humanos , Neoplasias/patologia , Proteínas Oncogênicas Virais/genética , Proteínas E7 de Papillomavirus , Fosfotransferases/análise , Fosfotransferases/genética , Interferência de RNA , RNA Interferente Pequeno/farmacologia , Transdução de Sinais
13.
CSH Protoc ; 2006(1)2006 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-22485666
14.
CSH Protoc ; 2006(1)2006 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-22485667
15.
CSH Protoc ; 2006(1)2006 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-22485668
16.
CSH Protoc ; 2006(1)2006 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-22485669
17.
CSH Protoc ; 2006(1)2006 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-22485670
20.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...